Cell and Gene Therapy Strategic Roundup | Sep 1 – Oct 6, 2026
Gene and cell therapy competition is shifting beyond efficacy. Durability,…
ERS 2026 Preview: Respiratory Therapies and Competitive Trends
ERS 2026 at a glance Will respiratory treatment differentiation increasingly…
Public Health Today—May 29, 2026
This week’s public health update covers advances in cardiovascular and…
Respiratory Video Recap—March 6, 2026
Respiratory biweekly video recap covering regulatory milestones, clinical trial…
Hematology Today—March 2, 2026
This is a weekly update in Hematology, covering key regulatory actions,…
Cell and Gene Therapy Today—January 29, 2026
This week’s Cell and Gene Therapy update highlights significant advancements,…
Lucid Diligence Brief: Seamless Therapeutics and Lilly enter gene-writing pact in hearing loss
Lucid Diligence Brief: Seamless Therapeutics and Lilly enter gene-writing pact…
Rare Disease Today—January 15, 2026
This week’s Rare Disease update highlights major developments, spanning…
Lucid Diligence Brief: Aurora Therapeutics launches to scale personalized CRISPR
Lucid Diligence Brief: Aurora Therapeutics launches to scale personalized…
Lucid Diligence Brief: CorriXR × InhaTarget × Merxin, inhaled CRISPR therapy for lung cancer
Lucid Diligence Brief: CorriXR × InhaTarget × Merxin, inhaled CRISPR therapy…
Lucid Diligence Brief: Regeneron and Tessera team on TSRA-196 for AATD
Lucid Diligence Brief: Regeneron and Tessera team on TSRA-196 for AATD…
Public Health Today—14 November, 2025
This weekly roundup spans late-stage trial wins, real-world and epidemiologic…